Sort
8,912 grants matching “sars cov 2”
CENTER FOR RESEARCH ON STRUCTURAL BIOLOGY OF INFECTIOUS DISEASES: SARS-CoV-2 RESEARCH
$808,960Karla Satchell · Northwestern University At Chicago · N01 · FY2023 · AI
Multi Parametric Total-Body Imaging of Immune Activation in Post Acute Sequelae of SARS-CoV-2 (PASC)
$808,672Negar Omidvari · University Of California At Davis · R01 · FY2025 · AI
mRNA Nuclear Export Machinery as Target of SARS-CoV-2 Nsp1 Protein
$807,958Yi Ren · Vanderbilt University · R01 · FY2025 · AI
Evolution of T cell immunity in blood and tissues over childhood
$807,646Donna L Farber · Columbia University Health Sciences · U01 · FY2024 · AI
Evolution of T cell immunity in blood and tissues over childhood
$807,646Donna L Farber · Columbia University Health Sciences · U01 · FY2023 · AI
Evolution of T cell immunity in blood and tissues over childhood
$807,646Donna L Farber · Columbia University Health Sciences · U01 · FY2025 · AI
Temporal Phenotypes and Risk Models for the Post-COVID Syndrome and its sub-types
$807,376Hossein Estiri · Massachusetts General Hospital · R01 · FY2025 · AI
When are in-person HIV services worth the risk of COVID-19 and other communicable illnesses? Optimizing choices when virtual services are less effective
$807,340Anna Bershteyn · New York University School Of Medicine · R01 · FY2022 · MH
Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)
$807,142Juan C Salazar · Connecticut Children'S Medical Center · R61 · FY2022 · HD
Center for Clinical and Translational Science
$807,056Robert P Kimberly · University Of Alabama At Birmingham · UL1 · FY2021 · TR
Pre-exposure Immunologic Health and Linkages to SARS-COV2 Serologic Responses, Endothelial Cell Resilience, and Cardiovascular Complications: Defining the mechanistic basis of high risk endotypes.
$806,907David A. Zidar · Case Western Reserve University · U01 · FY2023 · CA
Trusted Messengers: Supporting Physicians in Promoting COVID-19 Vaccination
$806,899Kimberly Fisher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · MD
Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimerâs disease in Ancestral and Admixed Populations
$806,739Gabriel Alejandro De Erausquin · University Of Texas Hlth Science Center · U19 · FY2025 · AG
Targeted treatment of acute lung injury using isolated lung perfusion
$806,617Irving L Kron · University Of Virginia · R01 · FY2025 · HL
Development of pan-betacoronavirus vaccines
$805,612Raiees Ahmad Andrabi · Scripps Research Institute, The · R01 · FY2023 · AI
ACE2-targeted PET radiotracers for investigating spatiotemporal distribution of SARS-CoV-2 organ injury and therapy response.
$805,361David M Wilson · University Of California, San Francisco · R01 · FY2023 · AI
Pulmonary pathophysiology sub-phenotypes of pneumonia
$805,021Joseph P Mizgerd · Boston University Medical Campus · R01 · FY2024 · AI
Viral and Host Dynamics during Pediatric COVID-19 and Respiratory Virus Co-Infection
$804,976Judd F Hultquist · Northwestern University At Chicago · R01 · FY2024 · AI
COVID-19-related blood-brain barrier and microstructural brain injury; Sex differences and synergy with Alzheimer's disease risk
$804,670Emilie T. Reas · University Of California, San Diego · R01 · FY2023 · AG
BREATHE - Bridging Research, Lung Health, and the Environment - Children's Center
$803,850Meredith C McCormack · Johns Hopkins University · P2C · FY2024 · ES
Mechanisms of atherosclerotic cardiovascular complications in COVID19
$803,677Chiara Giannarelli · New York University School Of Medicine · R01 · FY2022 · HL
Cardiovascular Risk, Vascular and Kidney Damage in COVID-19 Survivors
$803,324Julio Alonso Chirinos Medina · University Of Pennsylvania · R01 · FY2022 · HL
Evaluation of Oropharyngeal responses to SARS-CoV-2
$803,248Pamela Schwartzberg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
$802,815Charles Bix Shoemaker · Tufts University Boston · R01 · FY2024 · AI
Long term adverse health outcomes for women and children following SARS-CoV-2 infection during pregnancy
$802,700Monique Marie Hedderson · Kaiser Foundation Research Institute · R01 · FY2023 · AI